350 related articles for article (PubMed ID: 9608495)
41. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients.
Grossi P; Farina C; Fiocchi R; Dalla Gasperina D
Transplantation; 2000 Jul; 70(1):112-6. PubMed ID: 10919584
[TBL] [Abstract][Full Text] [Related]
42. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients.
Jantunen E; Salonen J; Juvonen E; Koivunen E; Siitonen T; Lehtinen T; Kuittinen O; Leppä S; Anttila VJ; Itälä M; Wiklund T; Remes K; Nousiainen T
Eur J Haematol; 2004 Sep; 73(3):174-8. PubMed ID: 15287914
[TBL] [Abstract][Full Text] [Related]
43. Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole.
Watanabe N; Matsumoto K; Kojima S; Kato K
J Pediatr Hematol Oncol; 2011 May; 33(4):270-5. PubMed ID: 21464763
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
Cornely OA; Böhme A; Reichert D; Reuter S; Maschmeyer G; Maertens J; Buchheidt D; Paluszewska M; Arenz D; Bethe U; Effelsberg J; Lövenich H; Sieniawski M; Haas A; Einsele H; Eimermacher H; Martino R; Silling G; Hahn M; Wacker S; Ullmann AJ; Karthaus M;
J Antimicrob Chemother; 2008 Apr; 61(4):939-46. PubMed ID: 18272515
[TBL] [Abstract][Full Text] [Related]
45. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O
Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840
[TBL] [Abstract][Full Text] [Related]
46. Microbiological findings of culture-positive preservation fluid in liver transplantation.
Janny S; Bert F; Dondero F; Durand F; Guerrini P; Merckx P; Nicolas-Chanoine MH; Belghiti J; Mantz J; Paugam-Burtz C
Transpl Infect Dis; 2011 Feb; 13(1):9-14. PubMed ID: 20738832
[TBL] [Abstract][Full Text] [Related]
47. Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team.
Alangaden G; Chandrasekar PH; Bailey E; Khaliq Y
Bone Marrow Transplant; 1994 Dec; 14(6):919-24. PubMed ID: 7711669
[TBL] [Abstract][Full Text] [Related]
48. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
[TBL] [Abstract][Full Text] [Related]
49. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
[TBL] [Abstract][Full Text] [Related]
50. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
51. [Invasive fungal infections in patients with blood disorders].
López F; Jarque I; Martín G; Sanz GF; Palau J; Martínez J; de la Rubia J; Larrea L; Arnao M; Solves P; Cervera J; Martínez ML; Pemán J; Gobernado M; Sanz MA
Med Clin (Barc); 1998 Mar; 110(11):401-5. PubMed ID: 9608494
[TBL] [Abstract][Full Text] [Related]
52. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Ringdén O; Andström EE; Remberger M; Dahllöf G; Svahn BM; Tollemar J
Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772
[TBL] [Abstract][Full Text] [Related]
53. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.
Noskin G; Pietrelli L; Gurwith M; Bowden R
Bone Marrow Transplant; 1999 Apr; 23(7):697-703. PubMed ID: 10218847
[TBL] [Abstract][Full Text] [Related]
54. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
[TBL] [Abstract][Full Text] [Related]
55. [Nosocomial fungal infections, analysis of 149 cases].
Liu ZY; Sheng RY; Li XL; Li TS; Wang AX
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):399-402. PubMed ID: 12820917
[TBL] [Abstract][Full Text] [Related]
56. Acute myelogenous leukemia patients are at low risk for invasive fungal infections after high-dose cytarabine consolidations and thus do not require prophylaxis.
Lewis G; Hall P; Eisa N; Deremer D; Dobbins R; El-Geneidy M; Jillella A; Ustun C
Acta Haematol; 2010; 124(4):206-13. PubMed ID: 21071929
[TBL] [Abstract][Full Text] [Related]
57. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM;
Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037
[TBL] [Abstract][Full Text] [Related]
58. High-dose fluconazole therapy in Intensive Care Unit.
De Bellis P; Bonfiglio M; Gerbi G; Bacigalupo P; Buscaglia G; Guido P; Massobrio B
Minerva Anestesiol; 2003 Mar; 69(3):145-52, 153-57. PubMed ID: 12792583
[TBL] [Abstract][Full Text] [Related]
59. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
Biancofiore G; Bindi ML; Baldassarri R; Romanelli AM; Catalano G; Filipponi F; Vagelli A; Mosca F
Transpl Int; 2002 Jul; 15(7):341-7. PubMed ID: 12122510
[TBL] [Abstract][Full Text] [Related]
60. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH
Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
